Skip to main navigation Skip to search Skip to main content

Clinical, virologic, and immunologic response to efavirenz- or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study)

  • John G. Bartlett

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)252
Number of pages1
JournalInfectious Diseases in Clinical Practice
Volume12
Issue number4
DOIs
StatePublished - 2004
Externally publishedYes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this